In accordance with the conditions of VIP > 1 and p < 0.05, a total of 102 differential metabolites including 84 upregulated and 18 downregulated in T2DM(+) HCC patients were finally identified (Table S2). The gene discussed is VIP; the disease is hepatocellular carcinoma.